With our in-house technology platform, scientific expertise in the inner ear, and network of experts, Sensorion can continually develop and optimize its pipeline and market expertise. Consequently, we are poised to expand our pipeline and facilitate other pharmaceutical collaborations.

We select and develop drug candidates from a pool of compounds in late pre-clinical and clinical stage development obtained from partnerships, collaborations and publically available drug libraries.

Sensorion has two therapeutic solutions being evaluated in clinical trials:
SENS-111 and SENS-401

2018 02 pipeline

Latest news

  • 13 Jul 2018

    Bilan semestriel du contrat de liquidité Sensorion avec la société de bourse Kepler Cheuvreux. Read (in french only)

  • 04 Jul 2018

    Information relative au nombre total de droits de vote et d’actions composant le capital social. Lire

Patient center

Corporate presentation